STERIS plc STE · USD
Health Care · Health Care Equipment & Supplies · US listing · 🇺🇸 United States
S&P 500
256.94
+1.84%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About STERIS plc
From its filings with the US Securities and Exchange Commission
STERIS plc is based in Dublin, Ireland and is incorporated in Ireland. Its shares trade on NYSE under the ticker STE. It is a member of the S&P 500. The SEC classifies its business as orthopedic, prosthetic & surgical appliances & supplies. In the fiscal year to 31 March 2026, it reported revenue of $5.94bn and net income of $782.3m. At that date it held total assets of $10.74bn and shareholders' equity of $7.18bn.
STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention. WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science products and services around the globe. We offer our Customers a unique mix of innovative products and services. These include: consumable products, such as detergents, endoscopy accessories, barrier products, instruments and tools; services, including equipment installation and maintenance, microbial reduction of medical devices, instrument and scope repair, laboratory testing, and outsourced reprocessing; capital equipment, such as sterilizers, surgical tables, and automated endoscope reprocessors; and connectivity solutions such as operating room (“OR”) integration.
The bulk of our revenues are derived from healthcare, medical device and pharmaceutical Customers. Much of the growth in these industries is driven by the aging of the population throughout the world, as an increasing number of individuals are entering their prime healthcare consumption years, and is dependent upon advancement in healthcare delivery, acceptance of new technologies, government policies, and general economic conditions.
Quoted from its 10-K, filed 29 May 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 3 Nov 2015
- Employees
- 18,000
- Website
- steris.com ↗
- Head office
- 70 SIR JOHN ROGERSON'S QUAY, DUBLIN, L2, 2
- Incorporated in
- L2
- Classification
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- Filer status
- Large accelerated filer
Leadership
Pay as last reported
- Dr. Mohsen SohiIndependent Chairman of the Board$503,868
- Mr. Daniel CarestioPresident, Chief Executive Officer, Director, since 2015$10.7m
- Ms. Karen BurtonChief Financial Officer, Senior Vice President
- Mr. Michael TokichChief Financial Officer, Senior Vice President$3.3m
- Ms. Mary FraserChief Human Resources Officer, Senior Vice President$1.9m
- Mr. John ZangerleSenior Vice President, General Counsel, Company Secretary$2.9m
- Mr. Kenneth KohlerSenior Vice President, General Manager - AST
- Ms. Julia MadsenSenior Vice President and General Manager - Life Sciences
- Mr. Cary MajorsSenior Vice President and President - Healthcare$2.2m
- Mr. Renato TamaroVice President, Corporate Treasurer
- Dr. Esther AlegriaIndependent Director$334,803
- Mr. Richard BreedenIndependent Director$353,903
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 67
- Environment
- 73
- Social
- 99
- Governance
- 29
- Direct emissions (scope 1)
- 57,543 t
- Energy emissions (scope 2)
- 96,291 t
- Value chain emissions (scope 3)
- 321,013 t
- Women in the workforce
- 34.91%
- Carbon reduction policy
- No
- Human rights policy
- Yes
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.